AstraZeneca shared a post on LinkedIn:
“Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia, yet many aspects of the patient experience remain overlooked.
As Blood Cancer Awareness Month begins, we recognise the vital role of the CLL community, including patient organisations such as the CLL Advocates Network, in strengthening health literacy and empowering informed decisions. We can help improve outcomes and support those affected by CLL and other complex blood cancers by working together.
Proceed to the video attached to the post.
More posts featuring AstraZeneca on OncoDaily.